Related Experiment Videos
[Somatostatin analogue treatment in Graves' ophthalmopathy: a case report]
I Coloma-González1, E Mengual-Verdú, J R Domínguez-Escribano
1Hospital Universitario San Juan de Alicante, Alicante, España. icg_ct@yahoo.es
Case Report:
The effect of a somatostatin analogue in a patient with Graves' ophthalmopathy is presented, including data on the dose requirements and the results of therapy.
Discussion:
There are few effective options for the management of Graves' ophthalmopathy, a cell-mediated immune co-morbidity of thyroid disease. Somatostatin analogues inhibit lymphocyte proliferation and activation, and accumulate in the orbital tissue during the active ophthalmopathy. Because of this, such therapy is able to inactivate the ophthalmopathy without complications occurring.
Related Concept Videos
Graves' Disease I: Introduction
Graves Disease II: Pathophysiology
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...